CL
CORT icon

Choreo LLC’s Corcept Therapeutics CORT Stock Holding History

Choreo LLC’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Buy
+3,878
New +$234K ﹤0.01% 1241
2026
Q1 		– Sell
-3,659
Closed -$257K – 1629
2025
Q4 		$257K Sell
3,659
-107
-3% -$8.4K ﹤0.01% 1310
2025
Q3 		$313K Sell
3,766
-329
-8% -$23.8K ﹤0.01% 1203
2025
Q2 		$301K Sell
4,095
-289
-7% -$21K ﹤0.01% 1170
2025
Q1 		$501K Sell
4,384
-203
-4% -$12.4K 0.01% 830
2024
Q4 		$233K Sell
4,587
-535
-10% -$28K ﹤0.01% 1334
2024
Q3 		$239K Buy
+5,122
New +$182K ﹤0.01% 1357

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Choreo LLC's CORT Position: Q2 2026 in Review

Choreo LLC opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 3,878 shares worth $337K. The stake represents ﹤0.01% of the portfolio and ranks #1241 among its holdings. This is a return to the name: Choreo LLC previously reported a position in CORT as recently as Q4 2025.

Choreo LLC first reported a position in CORT in Q3 2024 and has held it in 7 quarters since. The position peaked at $501K in Q1 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Choreo LLC held 3,878 shares of Corcept Therapeutics worth $337K as of Q2 2026.
  • Corcept Therapeutics was a new Choreo LLC position in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1241 holding.
  • Choreo LLC first reported a position in Corcept Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Choreo LLC's Corcept Therapeutics position peaked at $501K in Q1 2025.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.